Active Ingredient: HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
Proprietary Name: RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;15MG;0.1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A087709
Product Number: 001
Approval Date: May 13, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status:
Discontinued
Patent and Exclusivity Information
